Not Yet Recruiting PHASE2/PHASE3 INTERVENTIONAL 2-arm
NCT06914310
Memantine as an Additive Therapy in Patients With Traumatic Brain Injury
Sponsor: Mansoura University
Updated 2 times since 2025 Last updated: Apr 3, 2025 Started: Mar 25, 2025 Primary completion: Aug 30, 2025 Completion: Nov 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE2/PHASE3 trial investigates Mild Traumatic Brain Injury and Moderate Traumatic Brain Injury (TBI) and is currently actively recruiting participants. Mansoura University leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
2 versions recorded-
Sep 2025 — Present [monthly]
Not Yet Recruiting PHASE2/PHASE3
-
May 2025 — Sep 2025 [monthly]
Not Yet Recruiting PHASE2/PHASE3
First recorded
Mar 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Mansoura University
Data source: Mansoura University
For direct contact, visit the study record on ClinicalTrials.gov .